HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Ser460Pro mutation in recombinant protein S Heerlen does not affect its APC-cofactor and APC-independent anticoagulant activities.

Abstract
Protein S is a vitamin K-dependent plasma protein that functions as an APC-cofactor, but also exhibits anticoagulant activity in the absence of APC. The Heerlen polymorphism of protein S is characterized by a Ser460Pro substitution and lacks glycosylation at Asn458. It is associated with decreased protein S levels due to selective deficiency of free protein S Heerlen. To understand the lack of thrombotic complications associated with the protein S Heerlen mutation, we compared recombinant protein S Heerlen, wild type (wt) protein S and plasma-derived protein S. wt-Protein S and protein S Heerlen each bound 1:1 to C4BP with dissociation constants of 0.27 and 0.33 nM, respectively. Both wt-protein S and protein S Heerlen, either free or in complex with C4BP, were equally active as prothrombinase inhibitors in the absence of APC. All three protein S preparations stimulated APC-catalyzed inactivation of normal FVa, FVa Leiden and FVIIIa to the same extent. If extrapolated to plasma, it is not likely that the decreased free protein S levels in carriers of the protein S Heerlen mutation are compensated by an increased anticoagulant activity of protein S Heerlen-C4BP complexes. It is possible that an unrecognized plasma factor selectively enhances the anticoagulant activity of protein S Heerlen. If not, the reduction of free protein S levels in heterozygous protein S Heerlen-carriers combined with (low) normal total protein S levels apparently minimally affects the total anticoagulant activity of protein S (APC-cofactor and APC-independent activity) and hence is not associated with increased risk of venous thrombosis.
AuthorsRory R Koenen, Lucio Gomes, Guido Tans, Jan Rosing, Tilman M Hackeng
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 91 Issue 6 Pg. 1105-14 (Jun 2004) ISSN: 0340-6245 [Print] Germany
PMID15175796 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Blood Coagulation Factors
  • Protein C
  • Protein S
  • Recombinant Proteins
  • protein S Heerlen
  • Complement C4b
  • Thromboplastin
Topics
  • Anticoagulants
  • Blood Coagulation Factors (metabolism)
  • Cell Line
  • Complement C4b (metabolism)
  • Humans
  • Mutation, Missense
  • Protein C (metabolism)
  • Protein S (genetics, metabolism)
  • Protein S Deficiency (complications, etiology, genetics)
  • Recombinant Proteins
  • Risk
  • Thromboplastin (antagonists & inhibitors)
  • Transfection
  • Venous Thrombosis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: